Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Codexis has announced the signing of a collaboration and license agreement with Takeda for the research and development of novel gene therapies for certain disease indications.
read more
WPD has entered into a development agreement with CNS for the development of several preclinical drug candidates including WP1122, which will be tested on a range of viruses including the coronavirus SARS-CoV-2.
read more
Debiopharm has entered into a worldwide, exclusive license & research agreement with 3BP to further the development of their radioligand program which targets the CAIX enzyme.
read more
Dr. Reddy’s Laboratories is voluntarily recalling four lots of Phytonadione Injectable Emulsion USP, 10 mg/mL, Single-Dose Ampules to the hospital level.
read more
INTEGRA’s Australian distributor, BioTools, has partnered with SNP to support COVID-19 testing using the ASSIST PLUS pipetting robot, helping the laboratory team to increase sample processing capacity and fast track COVID-19 assay development while ...
read more
BrightInsight announced a global digital health partnership with AstraZeneca.
read more
Expert System joins the fight against COVID-19 by granting biomedical researchers worldwide free access to its AI-based CRN tool effective immediately.
read more
Cobra Biologics and the Karolinska Institutet have been awarded €3 million emergency funding by Horizon 2020 for phase I testing of a DNA vaccine against COVID-19.
read more
During this COVID-19 pandemic, the FDA is working around the clock to make sure that Americans have access to safe food and medical products.
read more
I-Mab announced the appointment of Fernando J. Salle´s, Ph.D., CLP®, as Senior Vice President, Head of U.S. & EU Business Development, effective March 30, 2020.
read more
BioStem Life Sciences has received it’s ISBT 128 Registration from the ICCBBA.
read more
With several mega cap biopharma companies having their vital manufacturing steps in Chinese facilities, the novel coronavirus outbreak is putting the complicated global biopharma industry's supply chain under strain.
read more
Wednesday, April 01, 2020
Cambrex announced Troy Player has been appointed as President, Early Stage Development and Testing (ESDT).
read more
Wednesday, April 01, 2020
Kleo has entered into a research collaboration with GCLC to rapidly advance testing of both advanced technology platforms in combination as a potential therapy for COVID-19 patients.
read more
Wednesday, April 01, 2020
Horizon Discovery and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.
read more